Drug Shortage Report for APO-DORZO-TIMOP

Last updated on 2022-08-06 History
Report ID 161037
Drug Identification Number 02299615
Brand name APO-DORZO-TIMOP
Common or Proper name DORZO-TIMOP
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10 mL
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-17
Estimated end date 2022-08-26
Actual end date 2022-08-05
Shortage status Resolved
Updated date 2022-08-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-08-06 English Compare
v6 2022-08-05 French Compare
v5 2022-08-05 English Compare
v4 2022-06-30 French Compare
v3 2022-06-30 English Compare
v2 2022-05-20 French Compare
v1 2022-05-20 English Compare

Showing 1 to 7 of 7